Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4892]

A new tool for diagnosing cancer

A new tool for diagnosing cancer

Yearly re-scanning not needed for common brain tumour detected in 1 in 10 people

Yearly re-scanning not needed for common brain tumour detected in 1 in 10 people

Pretherapy imaging and dosimetry offer personalised treatment planning for thyroid cancer patients

Pretherapy imaging and dosimetry offer personalised treatment planning for thyroid cancer patients

Study hints at how cancer immunotherapy can be safer

Study hints at how cancer immunotherapy can be safer

Study sheds light on how breast cancer cells evade immune surveillance and survive in lymph nodes

Study sheds light on how breast cancer cells evade immune surveillance and survive in lymph nodes

Researcher to investigate the mechanics of mitosis to combat cancer

Researcher to investigate the mechanics of mitosis to combat cancer

FDA clears IND application for first-in-class TCR NK cell therapy for sarcoma

FDA clears IND application for first-in-class TCR NK cell therapy for sarcoma

$FDA grants accelerated approval to glofitamab-gxbm for selected relapsed or refractory large B-cell lymphomas$

FDA grants accelerated approval to glofitamab-gxbm for selected relapsed or refractory large B-cell lymphomas

A programme that looks for the most effective drugs for each patient’s cancer helps to personalise cancer treatments

A programme that looks for the most effective drugs for each patient’s cancer helps to personalise cancer...

FDA approves talazoparib with enzalutamide for HRR gene-mutated metastatic castration-resistant prostate cancer

FDA approves talazoparib with enzalutamide for HRR gene-mutated metastatic castration-resistant prostate cancer

More from ecancer